How Flatiron clinical research impacted the Beat AML® master trial

In 2016, the Leukemia and Lymphoma Society (LLS) established the Beat AML® Master Trial with the aim of advancing the treatment paradigm for Acute Myeloid Leukemia (AML) through collaboration across over 20+ sites, sponsors, and technology vendors. 

Learn how LLS partnered with Flatiron to provide multiple clinical trial solutions to meet the high demands and standards for Beat AML®.